Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 46brooklyn, Abbvie, Affinia, Alector, Bausch + Lomb, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Character Biosciences, City Therapeutics, Eli Lilly, Gilead, IGM, Inflammx, Intellia, Intra-cellular, Light Horse, Mediar, Novartis, Novo Nordisk, Repare, Sage, Samsung Bioepis, Sandoz, Vertex, Y-mabs, Zai Lab.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bayer,GSK, Mersana, Otsuka.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4DMT, Acumen, Accure, Arrivo, Dyne, Iecure, Inozyme, Marea, Mersana, Marea, Pfizer, Precision, Orexo, Tiziana, Tenpoint, Totus.

Biopharmas raising money in public or private financings, including: A2, Amylyx, Calidi, Eli Lilly, Kardigan, Numab, Rhygaze.

New hires and promotions in the biopharma industry, including: Amphista, Avacta, Avanzanite, Context, Hemab, Outrun, Yaqrit.

The top 10 biopharma stock gainers and losers for the week.

A quick look back at top stories.